Global Non-Alcoholic Steatohepatitis Biomarkers Market Research Report 2023

Non-Alcoholic Steatohepatitis Biomarkers Market

According to QYResearch’s new survey, global Non-Alcoholic Steatohepatitis Biomarkers market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-Alcoholic Steatohepatitis Biomarkers market research.

Key companies engaged in the Non-Alcoholic Steatohepatitis Biomarkers industry include Genfit, Prometheus Laboratories, Siemens Medical Solutions USA, BioPredictive, Quest Diagnostics, AstraZeneca Plc., Laboratory Corporation of America Holdings, Pfizer and Bristol-Myers Squibb Company, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Non-Alcoholic Steatohepatitis Biomarkers were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-Alcoholic Steatohepatitis Biomarkers market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-Alcoholic Steatohepatitis Biomarkers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Non-Alcoholic Steatohepatitis Biomarkers Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Hepatic Fibrosis Biomarkers

1.2.3 Serum Biomarkers

1.2.4 Oxidative Stress Biomarkers

1.2.5 Apoptosis Biomarkers

1.2.6 Others

1.3 Market by Application

1.3.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Pharmaceutical Company

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market Perspective (2018-2029)

2.2 Non-Alcoholic Steatohepatitis Biomarkers Growth Trends by Region

2.2.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Non-Alcoholic Steatohepatitis Biomarkers Historic Market Size by Region (2018-2023)

2.2.3 Non-Alcoholic Steatohepatitis Biomarkers Forecasted Market Size by Region (2024-2029)

2.3 Non-Alcoholic Steatohepatitis Biomarkers Market Dynamics

2.3.1 Non-Alcoholic Steatohepatitis Biomarkers Industry Trends

2.3.2 Non-Alcoholic Steatohepatitis Biomarkers Market Drivers

2.3.3 Non-Alcoholic Steatohepatitis Biomarkers Market Challenges

2.3.4 Non-Alcoholic Steatohepatitis Biomarkers Market Restraints

3.1 Global Top Non-Alcoholic Steatohepatitis Biomarkers Players by Revenue

3.1.1 Global Top Non-Alcoholic Steatohepatitis Biomarkers Players by Revenue (2018-2023)

3.1.2 Global Non-Alcoholic Steatohepatitis Biomarkers Revenue Market Share by Players (2018-2023)

3.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Non-Alcoholic Steatohepatitis Biomarkers Revenue

3.4 Global Non-Alcoholic Steatohepatitis Biomarkers Market Concentration Ratio

3.4.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Alcoholic Steatohepatitis Biomarkers Revenue in 2022

3.5 Non-Alcoholic Steatohepatitis Biomarkers Key Players Head office and Area Served

3.6 Key Players Non-Alcoholic Steatohepatitis Biomarkers Product Solution and Service

3.7 Date of Enter into Non-Alcoholic Steatohepatitis Biomarkers Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Non-Alcoholic Steatohepatitis Biomarkers Historic Market Size by Type (2018-2023)

4.2 Global Non-Alcoholic Steatohepatitis Biomarkers Forecasted Market Size by Type (2024-2029)

5.1 Global Non-Alcoholic Steatohepatitis Biomarkers Historic Market Size by Application (2018-2023)

5.2 Global Non-Alcoholic Steatohepatitis Biomarkers Forecasted Market Size by Application (2024-2029)

6.1 North America Non-Alcoholic Steatohepatitis Biomarkers Market Size (2018-2029)

6.2 North America Non-Alcoholic Steatohepatitis Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2018-2023)

6.4 North America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size (2018-2029)

7.2 Europe Non-Alcoholic Steatohepatitis Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2018-2023)

7.4 Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size (2018-2029)

8.2 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region (2018-2023)

8.4 Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market Size (2018-2029)

9.2 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2018-2023)

9.4 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size (2018-2029)

10.2 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2018-2023)

10.4 Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Genfit

11.1.1 Genfit Company Detail

11.1.2 Genfit Business Overview

11.1.3 Genfit Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.1.4 Genfit Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.1.5 Genfit Recent Development

11.2 Prometheus Laboratories

11.2.1 Prometheus Laboratories Company Detail

11.2.2 Prometheus Laboratories Business Overview

11.2.3 Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.2.4 Prometheus Laboratories Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.2.5 Prometheus Laboratories Recent Development

11.3 Siemens Medical Solutions USA

11.3.1 Siemens Medical Solutions USA Company Detail

11.3.2 Siemens Medical Solutions USA Business Overview

11.3.3 Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.3.4 Siemens Medical Solutions USA Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.3.5 Siemens Medical Solutions USA Recent Development

11.4 BioPredictive

11.4.1 BioPredictive Company Detail

11.4.2 BioPredictive Business Overview

11.4.3 BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.4.4 BioPredictive Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.4.5 BioPredictive Recent Development

11.5 Quest Diagnostics

11.5.1 Quest Diagnostics Company Detail

11.5.2 Quest Diagnostics Business Overview

11.5.3 Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.5.4 Quest Diagnostics Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.5.5 Quest Diagnostics Recent Development

11.6 AstraZeneca Plc.

11.6.1 AstraZeneca Plc. Company Detail

11.6.2 AstraZeneca Plc. Business Overview

11.6.3 AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.6.4 AstraZeneca Plc. Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.6.5 AstraZeneca Plc. Recent Development

11.7 Laboratory Corporation of America Holdings

11.7.1 Laboratory Corporation of America Holdings Company Detail

11.7.2 Laboratory Corporation of America Holdings Business Overview

11.7.3 Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.7.4 Laboratory Corporation of America Holdings Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.7.5 Laboratory Corporation of America Holdings Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Detail

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.8.4 Pfizer Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.8.5 Pfizer Recent Development

11.9 Bristol-Myers Squibb Company

11.9.1 Bristol-Myers Squibb Company Company Detail

11.9.2 Bristol-Myers Squibb Company Business Overview

11.9.3 Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.9.4 Bristol-Myers Squibb Company Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.9.5 Bristol-Myers Squibb Company Recent Development

11.10 NGM Biopharmaceuticals

11.10.1 NGM Biopharmaceuticals Company Detail

11.10.2 NGM Biopharmaceuticals Business Overview

11.10.3 NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.10.4 NGM Biopharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.10.5 NGM Biopharmaceuticals Recent Development

11.11 Gilead Sciences

11.11.1 Gilead Sciences Company Detail

11.11.2 Gilead Sciences Business Overview

11.11.3 Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.11.4 Gilead Sciences Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.11.5 Gilead Sciences Recent Development

11.12 Perspectum Diagnostics

11.12.1 Perspectum Diagnostics Company Detail

11.12.2 Perspectum Diagnostics Business Overview

11.12.3 Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.12.4 Perspectum Diagnostics Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.12.5 Perspectum Diagnostics Recent Development

11.13 One Way Liver SL

11.13.1 One Way Liver SL Company Detail

11.13.2 One Way Liver SL Business Overview

11.13.3 One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.13.4 One Way Liver SL Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.13.5 One Way Liver SL Recent Development

11.14 Enterome SA

11.14.1 Enterome SA Company Detail

11.14.2 Enterome SA Business Overview

11.14.3 Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.14.4 Enterome SA Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.14.5 Enterome SA Recent Development

11.15 Echosens SA

11.15.1 Echosens SA Company Detail

11.15.2 Echosens SA Business Overview

11.15.3 Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.15.4 Echosens SA Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.15.5 Echosens SA Recent Development

11.16 Cisbio Bioassays SAS

11.16.1 Cisbio Bioassays SAS Company Detail

11.16.2 Cisbio Bioassays SAS Business Overview

11.16.3 Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.16.4 Cisbio Bioassays SAS Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.16.5 Cisbio Bioassays SAS Recent Development

11.17 Celerion Inc.

11.17.1 Celerion Inc. Company Detail

11.17.2 Celerion Inc. Business Overview

11.17.3 Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.17.4 Celerion Inc. Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.17.5 Celerion Inc. Recent Development

11.18 Xeptagen SpA

11.18.1 Xeptagen SpA Company Detail

11.18.2 Xeptagen SpA Business Overview

11.18.3 Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.18.4 Xeptagen SpA Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.18.5 Xeptagen SpA Recent Development

11.19 Boehringer Ingelheim

11.19.1 Boehringer Ingelheim Company Detail

11.19.2 Boehringer Ingelheim Business Overview

11.19.3 Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Introduction

11.19.4 Boehringer Ingelheim Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

11.19.5 Boehringer Ingelheim Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Hepatic Fibrosis Biomarkers

    Table 3. Key Players of Serum Biomarkers

    Table 4. Key Players of Oxidative Stress Biomarkers

    Table 5. Key Players of Apoptosis Biomarkers

    Table 6. Key Players of Others

    Table 7. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share by Region (2018-2023)

    Table 11. Global Non-Alcoholic Steatohepatitis Biomarkers Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share by Region (2024-2029)

    Table 13. Non-Alcoholic Steatohepatitis Biomarkers Market Trends

    Table 14. Non-Alcoholic Steatohepatitis Biomarkers Market Drivers

    Table 15. Non-Alcoholic Steatohepatitis Biomarkers Market Challenges

    Table 16. Non-Alcoholic Steatohepatitis Biomarkers Market Restraints

    Table 17. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share by Players (2018-2023)

    Table 19. Global Top Non-Alcoholic Steatohepatitis Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis Biomarkers as of 2022)

    Table 20. Ranking of Global Top Non-Alcoholic Steatohepatitis Biomarkers Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Non-Alcoholic Steatohepatitis Biomarkers Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Non-Alcoholic Steatohepatitis Biomarkers Product Solution and Service

    Table 24. Date of Enter into Non-Alcoholic Steatohepatitis Biomarkers Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue Market Share by Type (2018-2023)

    Table 28. Global Non-Alcoholic Steatohepatitis Biomarkers Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue Market Share by Type (2024-2029)

    Table 30. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue Market Share by Application (2018-2023)

    Table 32. Global Non-Alcoholic Steatohepatitis Biomarkers Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue Market Share by Application (2024-2029)

    Table 34. North America Non-Alcoholic Steatohepatitis Biomarkers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Genfit Company Detail

    Table 50. Genfit Business Overview

    Table 51. Genfit Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 52. Genfit Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 53. Genfit Recent Development

    Table 54. Prometheus Laboratories Company Detail

    Table 55. Prometheus Laboratories Business Overview

    Table 56. Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 57. Prometheus Laboratories Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 58. Prometheus Laboratories Recent Development

    Table 59. Siemens Medical Solutions USA Company Detail

    Table 60. Siemens Medical Solutions USA Business Overview

    Table 61. Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 62. Siemens Medical Solutions USA Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 63. Siemens Medical Solutions USA Recent Development

    Table 64. BioPredictive Company Detail

    Table 65. BioPredictive Business Overview

    Table 66. BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 67. BioPredictive Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 68. BioPredictive Recent Development

    Table 69. Quest Diagnostics Company Detail

    Table 70. Quest Diagnostics Business Overview

    Table 71. Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 72. Quest Diagnostics Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 73. Quest Diagnostics Recent Development

    Table 74. AstraZeneca Plc. Company Detail

    Table 75. AstraZeneca Plc. Business Overview

    Table 76. AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 77. AstraZeneca Plc. Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 78. AstraZeneca Plc. Recent Development

    Table 79. Laboratory Corporation of America Holdings Company Detail

    Table 80. Laboratory Corporation of America Holdings Business Overview

    Table 81. Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 82. Laboratory Corporation of America Holdings Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 83. Laboratory Corporation of America Holdings Recent Development

    Table 84. Pfizer Company Detail

    Table 85. Pfizer Business Overview

    Table 86. Pfizer Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 87. Pfizer Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 88. Pfizer Recent Development

    Table 89. Bristol-Myers Squibb Company Company Detail

    Table 90. Bristol-Myers Squibb Company Business Overview

    Table 91. Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 92. Bristol-Myers Squibb Company Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 93. Bristol-Myers Squibb Company Recent Development

    Table 94. NGM Biopharmaceuticals Company Detail

    Table 95. NGM Biopharmaceuticals Business Overview

    Table 96. NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 97. NGM Biopharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 98. NGM Biopharmaceuticals Recent Development

    Table 99. Gilead Sciences Company Detail

    Table 100. Gilead Sciences Business Overview

    Table 101. Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 102. Gilead Sciences Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 103. Gilead Sciences Recent Development

    Table 104. Perspectum Diagnostics Company Detail

    Table 105. Perspectum Diagnostics Business Overview

    Table 106. Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 107. Perspectum Diagnostics Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 108. Perspectum Diagnostics Recent Development

    Table 109. One Way Liver SL Company Detail

    Table 110. One Way Liver SL Business Overview

    Table 111. One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 112. One Way Liver SL Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 113. One Way Liver SL Recent Development

    Table 114. Enterome SA Company Detail

    Table 115. Enterome SA Business Overview

    Table 116. Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 117. Enterome SA Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 118. Enterome SA Recent Development

    Table 119. Echosens SA Company Detail

    Table 120. Echosens SA Business Overview

    Table 121. Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 122. Echosens SA Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 123. Echosens SA Recent Development

    Table 124. Cisbio Bioassays SAS Company Detail

    Table 125. Cisbio Bioassays SAS Business Overview

    Table 126. Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 127. Cisbio Bioassays SAS Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 128. Cisbio Bioassays SAS Recent Development

    Table 129. Celerion Inc. Company Detail

    Table 130. Celerion Inc. Business Overview

    Table 131. Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 132. Celerion Inc. Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 133. Celerion Inc. Recent Development

    Table 134. Xeptagen SpA Company Detail

    Table 135. Xeptagen SpA Business Overview

    Table 136. Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 137. Xeptagen SpA Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 138. Xeptagen SpA Recent Development

    Table 139. Boehringer Ingelheim Company Detail

    Table 140. Boehringer Ingelheim Business Overview

    Table 141. Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Product

    Table 142. Boehringer Ingelheim Revenue in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023) & (US$ Million)

    Table 143. Boehringer Ingelheim Recent Development

    Table 144. Research Programs/Design for This Report

    Table 145. Key Data Information from Secondary Sources

    Table 146. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share by Type: 2022 VS 2029

    Figure 3. Hepatic Fibrosis Biomarkers Features

    Figure 4. Serum Biomarkers Features

    Figure 5. Oxidative Stress Biomarkers Features

    Figure 6. Apoptosis Biomarkers Features

    Figure 7. Others Features

    Figure 8. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share by Application: 2022 VS 2029

    Figure 10. Hospital Case Studies

    Figure 11. Pharmaceutical Company Case Studies

    Figure 12. Others Case Studies

    Figure 13. Non-Alcoholic Steatohepatitis Biomarkers Report Years Considered

    Figure 14. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Non-Alcoholic Steatohepatitis Biomarkers Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share by Region: 2022 VS 2029

    Figure 17. Global Non-Alcoholic Steatohepatitis Biomarkers Market Share by Players in 2022

    Figure 18. Global Top Non-Alcoholic Steatohepatitis Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis Biomarkers as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Non-Alcoholic Steatohepatitis Biomarkers Revenue in 2022

    Figure 20. North America Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Non-Alcoholic Steatohepatitis Biomarkers Market Share by Country (2018-2029)

    Figure 22. United States Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Non-Alcoholic Steatohepatitis Biomarkers Market Share by Country (2018-2029)

    Figure 26. Germany Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Non-Alcoholic Steatohepatitis Biomarkers Market Share by Region (2018-2029)

    Figure 34. China Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market Share by Country (2018-2029)

    Figure 42. Mexico Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Market Share by Country (2018-2029)

    Figure 46. Turkey Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Non-Alcoholic Steatohepatitis Biomarkers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Genfit Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 49. Prometheus Laboratories Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 50. Siemens Medical Solutions USA Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 51. BioPredictive Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 52. Quest Diagnostics Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 53. AstraZeneca Plc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 54. Laboratory Corporation of America Holdings Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 55. Pfizer Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 56. Bristol-Myers Squibb Company Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 57. NGM Biopharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 58. Gilead Sciences Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 59. Perspectum Diagnostics Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 60. One Way Liver SL Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 61. Enterome SA Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 62. Echosens SA Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 63. Cisbio Bioassays SAS Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 64. Celerion Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 65. Xeptagen SpA Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 66. Boehringer Ingelheim Revenue Growth Rate in Non-Alcoholic Steatohepatitis Biomarkers Business (2018-2023)

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed